On Monday, CVS Health Corp (NYSE: CVS) opened lower -0.60% from the last session, before settling in for the closing price of $65.32. Price fluctuations for CVS have ranged from $43.56 to $71.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.79%. Company’s average yearly earnings per share was noted 9.11% at the time writing. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.26 billion.
Let’s determine the extent of company efficiency that accounts for 300000 employees. In terms of profitability, gross margin is 13.79%, operating margin of 2.28%, and the pretax margin is 1.65%.
CVS Health Corp (CVS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of CVS Health Corp is 0.14%, while institutional ownership is 84.43%. The most recent insider transaction that took place on Mar 05 ’25, was worth 498,488. In this transaction SVP, Cont & Chief Acct Officer of this company sold 7,513 shares at a rate of $66.35, taking the stock ownership to the 8,394 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 7,513 for $66.35, making the entire transaction worth $498,489.
CVS Health Corp (CVS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.53% during the next five years compared to -6.37% drop over the previous five years of trading.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Check out the current performance indicators for CVS Health Corp (CVS). In the past quarter, the stock posted a quick ratio of 0.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.22. Likewise, its price to free cash flow for the trailing twelve months is 12.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.66, a number that is poised to hit 1.67 in the next quarter and is forecasted to reach 6.89 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Looking closely at CVS Health Corp (NYSE: CVS), its last 5-days average volume was 7.94 million, which is a drop from its year-to-date volume of 11.2 million. As of the previous 9 days, the stock’s Stochastic %D was 23.27%. Additionally, its Average True Range was 2.18.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 76.62%, which indicates a significant increase from 12.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.52% in the past 14 days, which was lower than the 40.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $66.31, while its 200-day Moving Average is $58.94. However, in the short run, CVS Health Corp’s stock first resistance to watch stands at $65.99. Second resistance stands at $67.04. The third major resistance level sits at $67.94. If the price goes on to break the first support level at $64.04, it is likely to go to the next support level at $63.14. Now, if the price goes above the second support level, the third support stands at $62.09.
CVS Health Corp (NYSE: CVS) Key Stats
There are currently 1,260,795K shares outstanding in the company with a market cap of 81.97 billion. Presently, the company’s annual sales total 372,809 M according to its annual income of 4,614 M. Last quarter, the company’s sales amounted to 97,710 M and its income totaled 1,644 M.
